⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8512318 | 1.00 | — | — | |
| SCHEMBL3982650 | 0.73 | — | — | |
| SCHEMBL10921427 | 0.73 | — | — | |
| SCHEMBL17264871 | 0.71 | — | — | |
| SCHEMBL348016 | 0.71 | — | — | |
| SCHEMBL348015 | 0.71 | — | — | |
| SCHEMBL25438032 | 0.69 | ALDH1A1 (0.43) | — | |
| SCHEMBL10784066 | 0.67 | ALDH1A1 (0.42) | — | |
| SCHEMBL27634740 | 0.67 | — | — | |
| SCHEMBL11744673 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200330400-A1 | METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS | BERG LLC | 2020-10-22 | — | — | US | claimed |
| WO-2017161205-A1 | METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS | BERG LLC (US) | 2017-09-21 | — | — | WO | claimed |
| EP-2445506-B1 | THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AGAINST DISEASES CAUSED BY PROTOZOANS, VIRAL INFECTIONS AND CANCER | ENTARCO SA (GR) | 2014-12-31 | — | — | EP | claimed |
| WO-2014018801-A1 | DIAGNOSIS AND TREATMENT OF CANCER USING DIFFERENTIALLY EXPRESSED STARVATION MARKERS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2014-01-30 | — | — | WO | claimed |
| WO-2013071029-A1 | METHODS AND PRODUCTS FOR GENERATING OILS | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2013-05-16 | — | — | WO | claimed |
| US-8394377-B2 | Methods for treating cancer using combination therapy | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2013-03-12 | — | — | US | claimed |
| US-20130056683-A1 | COMPOSITIONS AND METHODS FOR PROMOTING FATTY ACID PRODUCTION IN PLANTS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2013-03-07 | — | — | US | claimed |
| US-8293240-B2 | Method of treating drug-resistant cancer | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2012-10-23 | — | — | US | claimed |
| WO-2012135632-A2 | METHODS OF TREATING A SUBJECT HAVING BEEN EXPOSED TO A CATASTROPHIC EVENT | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2012-10-04 | — | — | WO | claimed |
| EP-2486140-A2 | COMPOSITIONS AND METHODS FOR PROMOTING FATTY ACID PRODUCTION IN PLANTS | Regents of the University of Colorado (US) | 2012-08-15 | — | — | EP | claimed |
| US-20090258064-A1 | COMPOSITIONS OF UCP INHIBITORS, FAS ANTIBODY, A FATTY ACID METABOLISM INHIBITOR AND/OR A GLUCOSE METABOLISM INHIBITOR | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2009-10-15 | — | — | US | claimed |
| WO-2009105230-A2 | METHODS FOR TREATING CANCER USING COMBINATION THERAPY | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2009-08-27 | — | — | WO | claimed |
| EP-1651207-A4 | SYSTEMS AND METHODS FOR TREATING HUMAN INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS, WITH FATTY ACID METABOLISM INHIBITORS AND/OR GLYCOLYTIC INHIBITORS | UNIV COLORADO (US) | 2008-10-01 | — | — | EP | claimed |
| US-20060140953-A1 | Systems and methods for treating human inflammatory and proliferative diseases and wounds, with UCP and/or FAS antibody or other inhibitor, optionally with a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-06-29 | — | — | US | claimed |
| US-20060120971-A1 | Agents and methods for administration to the central nervous system | SIGNUM PHARMACEUTICALS, INC. | 2006-06-08 | — | — | US | claimed |
| EP-1651207-A2 | SYSTEMS AND METHODS FOR TREATING HUMAN INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS, WITH FATTY ACID METABOLISM INHIBITORS AND/OR GLYCOLYTIC INHIBITORS | The Board of Regents of the University of Colorado (US) | 2006-05-03 | — | — | EP | claimed |
| WO-2006041922-A2 | AGENTS AND METHODS FOR ADMINISTRATION TO THE CENTRAL NERVOUS SYSTEM | DARA BIOSCIENCES, INC. (US) | 2006-04-20 | — | — | WO | claimed |
| WO-2005070126-A2 | METHODS AND COMPOSITIONS FOR TREATING HUMAN DISEASES AND WOUNDS WITH UCP AND FAS INHIBITORS | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2005-08-04 | — | — | WO | claimed |
| US-20050020682-A1 | Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 2005-01-27 | — | — | US | claimed |
| WO-2004111199-A2 | SYSTEMS AND METHODS FOR TREATING HUMAN INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS, WITH FATTY ACID METABOLISM INHIBITORS AND/OR GLYCOLYTIC INHIBITORS | UNIVERSITY OF COLORADO SYSTEM TECHNOLOGY (US) | 2004-12-23 | — | — | WO | claimed |